+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gonorrhea Diagnostics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • PDF Icon

    Report

  • 116 Pages
  • January 2023
  • Region: Global
  • Acute Market Reports
  • ID: 5772622
Description Jump to:
Gonorrhea is caused due to the infection of the bacterium Neisseria gonorrhea which usually affects the moist and warm areas of the body such as the vagina, anus, urethra, throat, and eyes. It is classified as the second most occurring sexually transmitted disease (STD) as it has the risk to spread through unprotected sex or having multiple sex partners. The high morbidity rate and eminent threat of gonorrhea being resistant to cephalosporin make it necessary to understand the disease epidemiology of gonorrhea. As per the latest research citing the Centers for Disease Control and Prevention's 2016 report, the global prevalence of gonorrhea is 142.1 cases per 100,000 people. The occurrence is high in women in comparison to men and widely prevalent in regions such as North America, Latin America, Africa, and other developing nations of South Asia.

The World Health Organization has postulated a treatment guideline for gonorrhea to overcome the problem of microbial resistance, which consists of the use of antibiotics such as third-generation cephalosporins, doxycycline, azithromycin, gemifloxacin, etc. For effective diagnosis of gonorrhea, the cell culture standard test is considered as gold standard due to inherent features such as high specificity, high sensitivity, and relatively low cost. The problem associated with the cell culture of Neisseria is the need to maintain bacterial viability during storage and transport, and approximately 24-72 hours are required before a preliminary culture test result is obtained. The nucleic acid amplification test (NAAT) has been approved by the USFDA for analyzing genital specimens only and has been beneficial to gain positive results with very less genetic material, urine samples, and vaginal swabs. For analyzing extra genital specimens, gonorrhea diagnosis is performed with serological tests, monoclonal antibodies tests, and flow cytometry, etc.

Key players identified for the gonorrhea diagnostics market include:

Abbott Laboratories, Agilent Technologies, Beckman Coulter, Inc., Becton Dickinson & Company, bioMerieux, Inc., Cepheid, Inc., F. Hoffmann-La Roche AG, Ortho Clinical Diagnostics, PerkinElmer, Inc., Pfizer, Inc., Roche Diagnostics, Siemens AG, Tosoh Corporation and Others notable players.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Gonorrhea Diagnostics market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Gonorrhea Diagnostics market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

  • Flow Cytometry
  • Diagnostic Imaging
  • Gel Microdroplets
  • Chromatography
  • Liposomes
  • Monoclonal Antibodies Tests
  • Differential Light Scattering
  • Molecular Diagnostic Tests
  • Swab Tests
  • Nucleic Acid Amplification Tests (NAAT)

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Gonorrhea Diagnostics market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Gonorrhea Diagnostics market?
  • Which is the largest regional market for Gonorrhea Diagnostics market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Gonorrhea Diagnostics market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Gonorrhea Diagnostics market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Gonorrhea Diagnostics Market
2.2. Global Gonorrhea Diagnostics Market, By Type, 2022 (US$ Million)
2.3. Global Gonorrhea Diagnostics Market, By Geography, 2022 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2022

3. Gonorrhea Diagnostics Market: Competitive Analysis
3.1. Market Positioning of Key Gonorrhea Diagnostics Market Vendors
3.2. Strategies Adopted by Gonorrhea Diagnostics Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031

4. Gonorrhea Diagnostics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Gonorrhea Diagnostics Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Flow Cytometry
5.3.2. Diagnostic Imaging
5.3.3. Gel Microdroplets
5.3.4. Chromatography
5.3.5. Liposomes
5.3.6. Monoclonal Antibodies Tests
5.3.7. Differential Light Scattering
5.3.8. Molecular Diagnostic Tests
5.3.8.1. Swab Tests
5.3.8.2. Nucleic Acid Amplification Tests (NAAT)

6. North America Gonorrhea Diagnostics Market, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
6.3.Gonorrhea Diagnostics Market: By Region, 2021-2031, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)

7. UK and European Union Gonorrhea Diagnostics Market, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
7.3.Gonorrhea Diagnostics Market: By Region, 2021-2031, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
7.3.1.5. France
7.3.1.5.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)

8. Asia Pacific Gonorrhea Diagnostics Market, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
8.3.Gonorrhea Diagnostics Market: By Region, 2021-2031, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
8.3.1.3. India
8.3.1.3.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)

9. Latin America Gonorrhea Diagnostics Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
9.3.Gonorrhea Diagnostics Market: By Region, 2021-2031, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)

10. Middle East and Africa Gonorrhea Diagnostics Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
10.3.Gonorrhea Diagnostics Market: By Region, 2021-2031, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)

11. Company Profile
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Agilent Technologies
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Beckman Coulter, Inc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Becton Dickinson & Company
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. bioMerieux, Inc.
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Cepheid, Inc.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. F. Hoffmann-La Roche AG
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Ortho Clinical Diagnostics
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. PerkinElmer, Inc.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Pfizer, Inc.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. Roche Diagnostics
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives
11.12. Siemens AG
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Portfolio
11.12.4. Strategic Initiatives
11.13. Tosoh Corporation
11.13.1. Company Overview
11.13.2. Financial Performance
11.13.3. Product Portfolio
11.13.4. Strategic Initiatives
11.14. Others notable players
11.14.1. Company Overview
11.14.2. Financial Performance
11.14.3. Product Portfolio
11.14.4. Strategic Initiatives

List of Figures
Figure 1 Global Gonorrhea Diagnostics Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Gonorrhea Diagnostics Market: Quality Assurance
Figure 5 Global Gonorrhea Diagnostics Market, By Type, 2022
Figure 6 Global Gonorrhea Diagnostics Market, By Geography, 2022
Figure 7 Market Geographical Opportunity Matrix - Global Gonorrhea Diagnostics Market, 2022
Figure 8 Market Positioning of Key Gonorrhea Diagnostics Market Players, 2022
Figure 9 Global Gonorrhea Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure 10 Global Gonorrhea Diagnostics Market, By Type, 2022 Vs 2031, %
Figure 11 U.S. Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 12 Canada Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 13 Rest of North America Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 14 UK Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 15 Germany Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 16 Spain Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 17 Italy Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 18 France Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 19 Rest of Europe Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 20 China Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 21 Japan Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 22 India Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 23 Australia Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 24 South Korea Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 25 Rest of Asia Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 26 Brazil Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 27 Mexico Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 28 Rest of Latin America Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 29 GCC Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 30 Africa Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
Figure 31 Rest of Middle East and Africa Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031

List of Tables
Table 1 Global Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 12 Global Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 13 North America Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 14 North America Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 15 U.S. Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 16 U.S. Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 17 Canada Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 18 Canada Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 19 Rest of North America Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 110 Rest of North America Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 111 UK and European Union Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 112 UK and European Union Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 113 UK Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 114 UK Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 115 Germany Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 116 Germany Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 117 Spain Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 118 Spain Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 119 Italy Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 120 Italy Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 121 France Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 122 France Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 123 Rest of Europe Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 124 Rest of Europe Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 125 Asia Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 126 Asia Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 127 China Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 128 China Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 129 Japan Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 130 Japan Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 131 India Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 132 India Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 133 Australia Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 134 Australia Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 135 South Korea Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 136 South Korea Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 137 Latin America Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 138 Latin America Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 139 Brazil Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 140 Brazil Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 141 Mexico Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 142 Mexico Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 143 Rest of Latin America Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 144 Rest of Latin America Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 145 Middle East and Africa Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 146 Middle East and Africa Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 147 GCC Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 148 GCC Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 149 Africa Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 150 Africa Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
Table 151 Rest of Middle East and Africa Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
Table 152 Rest of Middle East and Africa Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter Inc
  • Becton Dickinson & Company
  • bioMerieux Inc
  • Cepheid Inc
  • F. Hoffmann-La Roche AG
  • Ortho Clinical Diagnostics
  • PerkinElmer Inc
  • Pfizer Inc
  • Roche Diagnostics
  • Siem

Related Topics

Related Reports

2024-2028 Global Gonorrhea Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Image

2024-2028 Global Gonorrhea Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • Global
From
Infectious Disease In-vitro Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Infectious Disease In-vitro Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 250 Pages
  • Global
STD Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

STD Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 113 Pages
  • Global
From
Sexually Transmitted Disease (STD) Testing Market Forecasts from 2023 to 2028 - Product Image

Sexually Transmitted Disease (STD) Testing Market Forecasts from 2023 to 2028

  • Report
  • 140 Pages
  • Global
From
Sexually Transmitted Diseases Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Sexually Transmitted Diseases Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From

About the Gonorrhea Test Market

The Gonorrhea Test market is a segment of the Infectious Disease Testing market. It is used to detect the presence of the bacteria Neisseria gonorrhoeae, which is the cause of the sexually transmitted infection gonorrhea. Tests for gonorrhea are typically conducted using a urine sample or a swab of the infected area. The results of the test are used to diagnose the infection and to determine the best course of treatment. Gonorrhea testing is widely available in both clinical and non-clinical settings. In clinical settings, tests are typically conducted by a healthcare provider and results are available within a few days. Non-clinical settings, such as pharmacies and home testing kits, offer rapid results and are becoming increasingly popular. Companies in the Gonorrhea Test market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Quidel, Roche Diagnostics, and Siemens Healthineers. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.